We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diet Augmented with Microgreens Lowers Cardiovascular Disease Risk

By LabMedica International staff writers
Posted on 27 Dec 2016
A diet augmented with red cabbage microgreens countered weight gain in a line of obese mice and reduced levels of cardiovascular disease indicators such as low-density lipoprotein cholesterol (LDL-c).

A microgreen is a tiny vegetable green that is used both as a visual and flavor component or ingredient primarily in fine dining restaurants. More...
Microgreens, which are smaller than “baby greens” and harvested later than “sprouts,” are produced from various kinds of vegetables, herbs, or other plants. They range in size from one to three inches in length including the stem and leaves. A microgreen has a single central stem, which has been cut just above the soil line during harvesting. It has fully developed cotyledon leaves and usually has one pair of very small, partially developed true leaves. The average crop-time for most microgreens is 10–14 days from seeding to harvest.

Since previous studies had shown that full-grown red cabbage could reduce excessive cholesterol, investigators at the U.S. Department of Agriculture (Beltsville, MD, USA) evaluated the possibility that red cabbage microgreens might have a similar or even greater effect than their larger counterparts.

The investigators used a rodent diet-induced obesity model to address this question. A population of 60 five-weeks old male C57BL/6NCr mice were randomly assigned to six feeding groups: (1) low-fat diet; (2) high-fat diet; (3) low-fat diet + red cabbage microgreens; (4) low-fat diet + mature red cabbage; (5) high-fat diet + red cabbage microgreens; (6) high-fat diet + mature red cabbage. The animals were maintained on their respective diets for eight weeks.

Results published in the December 7, 2016, issue of the Journal of Agricultural and Food Chemistry revealed that microgreen supplementation reversed high-fat diet induced weight gain. Moreover, supplementation with microgreens significantly lowered circulating LDL levels in animals fed the high-fat diet and reduced hepatic cholesterol ester, triacylglycerol levels, and expression of inflammatory cytokines in the liver.

Overall, the results suggested that microgreens could modulate weight gain and cholesterol metabolism and may protect against cardiovascular disease by lowering elevated cholesterol levels.

Related Links:
U.S. Department of Agriculture


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.